HEN3:XETRHenkel AG & Co. KGaA Pref Analysis
Data as of 2026-06-12 - not real-time
€68.48
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Henkel's stock is trading above its short‑term moving averages and shows a bullish MACD divergence, while RSI sits in the upper‑mid range, indicating modest momentum. The price is hugging a key resistance level just above the current market price, with a solid support zone a few euros lower, and volume has been on the rise, suggesting active buying interest.
Fundamentally, the company posted a slight dip in revenue but maintained healthy gross and operating margins, supports a dividend yield around three percent with a payout ratio below half, and carries a low net‑debt profile. However, a discounted cash‑flow model points to a fair value well below the current price, even as analyst consensus targets imply roughly ten percent upside. Low beta and defensive consumer‑goods exposure temper volatility, though recent earnings highlighted modest organic growth and an aggressive acquisition and buy‑back program.
Fundamentally, the company posted a slight dip in revenue but maintained healthy gross and operating margins, supports a dividend yield around three percent with a payout ratio below half, and carries a low net‑debt profile. However, a discounted cash‑flow model points to a fair value well below the current price, even as analyst consensus targets imply roughly ten percent upside. Low beta and defensive consumer‑goods exposure temper volatility, though recent earnings highlighted modest organic growth and an aggressive acquisition and buy‑back program.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance limits immediate upside
- Bullish MACD but elevated short‑term volatility
- Recent earnings beat and share‑buyback support
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst target price suggests ~10% upside
- Strategic acquisitions expanding earnings base
- Sustainable dividend and low net‑debt profile
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Defensive consumer‑goods sector with low systematic risk
- Consistent cash‑flow generation supporting dividend
- Valuation premium relative to DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth-6.30%
Profit Margin9.93%
P/E Ratio13.9
ROE9.71%
ROA5.09%
Debt/Equity18.02
P/B Ratio1.4
Op. Cash Flow€2.5B
Free Cash Flow€1.5B
Technical Analysis
TrendNeutral
RSI61.4
Support€63.22
Resistance€69.04
MA 20€66.44
MA 50€65.36
MA 200€70.58
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
Fair Value€46.10
Target Price€75.33
Upside/Downside10.01%
GradeOvervalued
TypeBlend
Dividend Yield3.01%
Risk Assessment
Beta0.05
Volatility23.64%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.